Seel
SEEL 519% upside according to this analyst SEEL Seelos Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders.
On 3/14/2022 B. Riley Lower Price Target Buy rating for SEEl from $6.00 to $4.00.
52 Week Range 0.76 - 6.60
Is this a strong buy? Looking forward to read your opinion about it.
NUMI (Numinus Wellness) Ready to Rocket - don't miss this oppAs the chart shows, the most beautiful falling wedge pattern right into a key support. Numinus likely to rocket back to previous ATH offering traders a chance at 400% gains - SHORT TERM!
Note: Numinus just applied to be listed on the Toronto Stock Exchange (TSX) pending some conditions. Add this Psychedelic leader to your portfolio.
Similar stocks: CMPS, ATAI, MNMD, CYBN, SEEL
www.fool.com